| NCT ID | NCT04796844 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Societa Italiana di Pneumologia |
| Condition | Asthma |
| Study Type | OBSERVATIONAL |
| Enrollment | 20,000 participants |
| Start Date | 2021-05-01 |
| Primary Completion | 2021-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20,000 participants in total. It began in 2021-05-01 with a primary completion date of 2021-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this registry aims is to collect a large number of patients with mild and moderate asthma in a real-word conditions for a perspective observation of epidemiological evolution of the disease in relation to the therapeutic interventions available currently and in the near future.
Eligibility Criteria
Inclusion Criteria: * Adult patients * Asthma diagnosis according GINA 2020 algorithm (Annex 1) * Patients enrolled in other previous or ongoing observational studies Exclusion Criteria: * Severe asthma patients according International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. \[Chung KF et al. European Respiratory Journal Feb 2014, 43 (2) 343-373; DOI: 10.1183/09031936.00202013 (Annex 2)\] * Subjects are excluded from this cohort if they exhibit interstitial lung diseases, pulmonary neoplasms, current lung infections, immunological disorders leading to the use of immunosuppressants or continuous treatment with oral steroids.
Contact & Investigator
Fulvio Braido
PRINCIPAL INVESTIGATOR
IRCCS Ospedale Policlinico San Martino, Department of Internal Medicine (DiMI), University of Genoa
Frequently Asked Questions
Who can join the NCT04796844 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04796844 currently recruiting?
Yes, NCT04796844 is actively recruiting participants. Contact the research team at fulvio.braido@unige.it for enrollment information.
Where is the NCT04796844 trial being conducted?
This trial is being conducted at Genova, Italy.
Who is sponsoring the NCT04796844 clinical trial?
NCT04796844 is sponsored by Societa Italiana di Pneumologia. The principal investigator is Fulvio Braido at IRCCS Ospedale Policlinico San Martino, Department of Internal Medicine (DiMI), University of Genoa. The trial plans to enroll 20,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.